Robyn J. Barst

Active 1986–2023

121
Papers
51,163
Citations
101
h-index
121
i10-index

Citations

Citations per year for Robyn J. Barst1960: 11 citations1979: 1 citations1982: 2 citations1985: 1 citations1988: 1 citations1989: 2 citations1990: 2 citations1992: 1 citations1993: 10 citations1994: 5 citations1995: 19 citations1996: 18 citations1997: 32 citations1998: 56 citations1999: 88 citations2000: 93 citations2001: 106 citations2002: 154 citations2003: 228 citations2004: 341 citations2005: 302 citations2006: 410 citations2007: 364 citations2008: 555 citations2009: 529 citations2010: 457 citations2011: 428 citations2012: 468 citations2013: 611 citations2014: 424 citations2015: 410 citations2016: 349 citations2017: 243 citations2018: 291 citations2019: 905 citations2020: 863 citations2021: 655 citations2022: 606 citations2023: 320 citations2024: 540 citations2025: 239 citations2026: 1 citations1961–1978: no citations, so these years are not shown1980–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown1986–1987: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,668 citing papers, 30.7% of this breakdownUnited Kingdom: 804 citing papers, 9.3% of this breakdownGermany: 603 citing papers, 6.9% of this breakdownFrance: 525 citing papers, 6% of this breakdownCanada: 453 citing papers, 5.2% of this breakdownItaly: 407 citing papers, 4.7% of this breakdownChina: 377 citing papers, 4.3% of this breakdownNetherlands: 343 citing papers, 3.9% of this breakdownSwitzerland: 232 citing papers, 2.7% of this breakdownJapan: 204 citing papers, 2.4% of this breakdownBelgium: 189 citing papers, 2.2% of this breakdownAustria: 187 citing papers, 2.2% of this breakdown
0%30.7%Other 19.5%

Fields

  • Medicine91.1%
  • Biochemistry, Genetics and Molecular Biology5.2%
  • Engineering0.9%
  • Immunology and Microbiology0.6%
  • Computer Science0.4%
  • Neuroscience0.4%
  • Other1.4%

Topics

  • Pulmonary Hypertension Research and Treatments23.6%
  • Cardiovascular Function and Risk Factors5.5%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis3.3%
  • Heart Failure Treatment and Management3.2%
  • Cardiovascular Issues in Pregnancy3.1%
  • Congenital Heart Disease Studies3.1%
  • Other58.2%

Coauthors

All papers

Open in search
  1. Survival in Patients with Primary Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 1991 cited by 3,506

  2. Pediatric Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2015 cited by 1,128

  3. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 2,470

  4. Predicting Survival in Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - Circulation 2010 cited by 1,550

  5. Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , - CHEST Journal 2009 cited by 1,180

  6. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

    Authors: , , , , , - CHEST Journal 2012 cited by 1,107

  7. Bosentan Therapy for Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2002 cited by 2,720

  8. Tadalafil Therapy for Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - Circulation 2009 cited by 1,094

  9. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 1996 cited by 2,695

  10. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2013 cited by 562

  11. Right Ventricular Function and Failure

    Authors: , , , , , , , , , , , , , - Circulation 2006 cited by 1,250

  12. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Authors: , , , , , , , , , , , , - Circulation 2009 cited by 2,355

  13. Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy

    Authors: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2010 cited by 383

  14. Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2006 cited by 613

  15. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease

    Authors: , , , , , , , , , , , , , , , - Circulation 2013 cited by 373

  16. Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial

    Authors: , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2002 cited by 1,407

  17. Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene

    Authors: , , , , , , , , , , , - The American Journal of Human Genetics 2000 cited by 1,207

  18. Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management

    Authors: , , , , , - CHEST Journal 2011 cited by 206

  19. Long-term safety and efficacy of imatinib in pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2015 cited by 148

  20. The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States

    Authors: , , , , , , , , , , , , - CHEST Journal 2010 cited by 351

  21. doi:https://doi.org/10.1016/j.ehj.2004.09.014

    Authors: , , , , , , , , , , - European Heart Journal 2004 cited by 1,048

  22. Portopulmonary Hypertension

    Authors: , , , , , , - CHEST Journal 2011 cited by 296

  23. Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2000 cited by 1,075

  24. Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2006 cited by 625